Bank Julius Baer & Co. Ltd, Zurich - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank Julius Baer & Co. Ltd, Zurich ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$26,000
+8.3%
13,131
+1.0%
0.00%
Q1 2021$24,000
+33.3%
13,000
+58.2%
0.00%
Q4 2020$18,0008,2190.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders